These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35948477)

  • 61. Comparative effectiveness of different chemotherapy regimens of advanced-stage Hodgkin lymphoma in adults: a network meta-analysis.
    Zhang T; Yao Y; Feng F; Zhao W; Tian J; Zhou C; Wang X; Dong S; Li J; Qi L; Sun C
    Cancer Manag Res; 2018; 10():6017-6028. PubMed ID: 30538551
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Treatment of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD).
    Papa G; Mandelli F; Anselmo AP; De Luca AM; Maurizienrici R; Mauro F; Testi AM; Amadori S; Biagini C
    Eur J Cancer Clin Oncol; 1982 Sep; 18(9):803-6. PubMed ID: 6185342
    [No Abstract]   [Full Text] [Related]  

  • 63. Advanced Hodgkin disease with large mediastinal involvement can be treated with eight cycles of chemotherapy alone after a major response to six cycles of chemotherapy: a study of 82 patients from the Groupes d'Etudes des Lymphomes de l'Adulte H89 trial.
    Brice P; Colin P; Berger F; de Kerviler E; Diviné M; Bouaffia F; Kerneis Y; Blanc M; Lepage E; Fermé C;
    Cancer; 2001 Aug; 92(3):453-9. PubMed ID: 11505388
    [TBL] [Abstract][Full Text] [Related]  

  • 64. MOPP treatment of resistant Hodgkin's disease following ABVD failure.
    Cimino G; Anselmo AP; Marzullo A; Maurizi Enrici R; Mauro F; Papa G; Mandelli F
    Tumori; 1983 Oct; 69(5):469-72. PubMed ID: 6196891
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Treating Adults with Hodgkin Lymphoma in the Developing World: a Hospital-Based Cohort Study from Armenia.
    Avagyan A; Danielyan S; Voskanyan A; Sargsyan L; Hakobyan L; Zohrabyan D; Safaryan L; Harutyunyan L; Bardakchyan S; Iskanyan S; Arakelyan S; Tamamyan G
    Asian Pac J Cancer Prev; 2016; 17(1):101-4. PubMed ID: 26838192
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial.
    Gallamini A; Tarella C; Viviani S; Rossi A; Patti C; Mulé A; Picardi M; Romano A; Cantonetti M; La Nasa G; Trentin L; Bolis S; Rapezzi D; Battistini R; Gottardi D; Gavarotti P; Corradini P; Cimminiello M; Schiavotto C; Parvis G; Zanotti R; Gini G; Ferreri AJM; Viero P; Miglino M; Billio A; Avigdor A; Biggi A; Fallanca F; Ficola U; Gregianin M; Chiaravalloti A; Prosperini G; Bergesio F; Chauvie S; Pavoni C; Gianni AM; Rambaldi A
    J Clin Oncol; 2018 Feb; 36(5):454-462. PubMed ID: 29360414
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Treatment of advanced Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide (ABVD) after failure of MOPP therapy.
    Krikorian JG; Portlock CS; Rosenberg SA
    Cancer; 1978 Jun; 41(6):2107-11. PubMed ID: 77716
    [TBL] [Abstract][Full Text] [Related]  

  • 68. HD2000 Update in Hodgkin Lymphoma-ABVD or BEACOPP?
    Vassilakopoulos TP; Johnson PWM
    J Clin Oncol; 2016 Oct; 34(29):3584-3585. PubMed ID: 27528721
    [No Abstract]   [Full Text] [Related]  

  • 69. ABVD treatment of MOPP failures in Hodgkin's disease: a re-examination of goals of salvage therapy.
    Clamon GH; Corder MP
    Cancer Treat Rep; 1978 Mar; 62(3):363-7. PubMed ID: 77188
    [No Abstract]   [Full Text] [Related]  

  • 70. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
    Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Effectiveness and toxicity of MOPP, ABVD, BEACOPP chemotherapy in first-diagnosed Hodgkin lymphoma with a poor prognosis].
    Filatova LV; Plotnikova AA; Gershanovich ML; Semiglazova TIu
    Vopr Onkol; 2013; 59(2):59-65. PubMed ID: 23814851
    [TBL] [Abstract][Full Text] [Related]  

  • 72. What is the treatment of choice for advanced-stage Hodgkin's lymphoma: ABVD, Stanford V, or BEACOPP?
    Hehn ST; Miller TP
    Curr Hematol Rep; 2004 Jan; 3(1):17-26. PubMed ID: 14695845
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Is BEACOPP better than ABVD?
    Cheson BD
    Curr Hematol Malig Rep; 2007 Jul; 2(3):161-6. PubMed ID: 20425365
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group.
    Eichenauer DA; Plütschow A; Kreissl S; Sökler M; Hellmuth JC; Meissner J; Mathas S; Topp MS; Behringer K; Klapper W; Kuhnert G; Dietlein M; Kobe C; Fuchs M; Diehl V; Engert A; Borchmann P
    Lancet Oncol; 2017 Dec; 18(12):1680-1687. PubMed ID: 29133014
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Retrospective analysis of clinical features and treatment outcomes of children with Hodgkin's Lymphoma treated with different chemotherapy protocols at a tertiary care center in Pakistan.
    Mehreen A; Wali RM; Sindhu II; Asad M; Ria S
    J Pak Med Assoc; 2019 Sep; 69(9):1266-1272. PubMed ID: 31511710
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Optimal treatment of early-stage Hodgkin disease.
    Sullivan JW; Cooper JS
    Radiology; 1993 Feb; 186(2):312-3. PubMed ID: 7678466
    [No Abstract]   [Full Text] [Related]  

  • 77. European experience with ifosfamide in lymphomas.
    von Kalle AK; Schaadt M; Diehl V
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):73-7. PubMed ID: 2468184
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
    Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
    [TBL] [Abstract][Full Text] [Related]  

  • 79. CCNU, etoposide, and prednimustine (CEP) in refractory Hodgkin's disease.
    Santoro A; Viviani S; Valagussa P; Bonfante V; Bonadonna G
    Semin Oncol; 1986 Mar; 13(1 Suppl 1):23-6. PubMed ID: 2420012
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Drug selection in the treatment of Hodgkin's disease.
    Bonadonna G; Santoro A
    Hematol Oncol; 1983; 1(1):3-12. PubMed ID: 6203820
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.